Additionally, AIP-related lipid abnormalities may inhibit endothelial nitric oxide synthase (eNOS), reducing nitric oxide (NO) bioavailability—a critical factor in vasodilation and anti-thrombotic defense (28). This evidence concerns the gene NOS3 and autoimmune pancreatitis.